Barclays »

Citius Oncology shares owned by Barclays

Quarter-by-quarter ownership of Citius Oncology (CTOR) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Citius Oncology

Tip: Access up to 7 years of quarterly data

All positions including Citius Oncology held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Oncology by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $59 90 0.66

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Citius Oncology

Armistice Capital
Bank of America Corporation
Vanguard Capital Management
UBS Group
Geode Capital Management
Vanguard Fiduciary Trust
IFP Advisors
Citadel Advisors
Northern Trust
State Street Corporation
Virtu Financial
XTX Topco
Tower Research Capital
Arkadios Wealth Advisors
Advisor Group Holdings

View all funds holding Citius Oncology